Marie Skougaard received her medical degree from University of Copenhagen in 2017. After graduation she was employed at the Department of Endocrinology, Bispebjerg Hospital, during 6 month of basic clinical training.
Marie has been associated with the Parker Institute since 2014 where she joined the institute during a pre-graduate research year as a part of the ELECTOR pre-grant project team. The ELECTOR project aim to develop home-based monitoring of patients with rheumatoid arthritis. From 2015 she has been in charge of recruitment and day-to-day contact with ELECTOR project participants during clinical trial I and various pilot trials.
Since June 2018 Marie has been enrolled as a PhD student at the Faculty of Health Sciences at University of Copenhagen. The PhD project focuses on how to provide personalized medicines for patients with psoriatic arthritis (PsA). A multi-layered project that combines
1) clinical research including a PsA patient cohort assessing clinical manifestations and outcomes of PsA patients initiating treatment with TNFα inihibitor, IL17 inihibitor, or methotrexate
2) investigation of immune cellular signatures and mechanisms including laboratory techniques; flow cytometry to assess immune cell phenotypes, multiplex immunoassay to characterize cytokine signatures and single cell RNA sequencing to explore gene expression profiles of PsA patients before and after treatment – all are conducted on biosamples from the PsA patient cohort
3) patient-reported outcome to assess quality of life in PsA patient
Alongside her PhD project, Marie works with senior researcher Tanja Schjødt Jørgensen in Value Based Outcomes Unit and is a constituted board member in the Parker Institutes Patient Association